Accent Capital Management’s GSK GSK Stock Holding History

Accent Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$41.3K	Hold	781	–	–	0.02%	117
2026 Q1	$43.1K	Buy	+781	New	+$42.3K	0.02%	114
2025 Q3	–	Sell	-120	Closed	-$4.66K	–	397
2025 Q2	$4.66K	Hold	120	–	–	﹤0.01%	337
2025 Q1	$5.02K	Sell	120 -800	-87%	-$29.3K	﹤0.01%	255
2024 Q4	$31.5K	Hold	920	–	–	0.02%	93
2024 Q3	$38K	Hold	920	–	–	0.02%	106
2024 Q2	$35.4K	Hold	920	–	–	0.02%	108
2024 Q1	$39.8K	Hold	920	–	–	0.03%	86
2023 Q4	$34.1K	Buy	+920	New	+$33K	0.03%	117

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Accent Capital Management's GSK Position: Q2 2026 in Review

Accent Capital Management held its GSK (GSK) position steady in Q2 2026 at 781 shares worth $41.3K. The position accounts for 0.02% of the portfolio, ranked #117.

Accent Capital Management first reported a position in GSK in Q4 2023 and has held it in 9 quarters since. The position peaked at $43.1K in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Accent Capital Management held 781 shares of GSK worth $41.3K as of Q2 2026.
Accent Capital Management left its GSK share count unchanged in Q2 2026.
GSK made up 0.02% of Accent Capital Management's portfolio in Q2 2026, its #117 holding.
Accent Capital Management first reported a position in GSK in Q4 2023 and has held it in 9 quarters since.
Accent Capital Management's GSK position peaked at $43.1K in Q1 2026.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Accent Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.